A team of researchers at Tel Aviv University has announced a potential breakthrough in the fight against amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease with no known cure. The scientists have identified a previously unknown molecular mechanism driving the disease’s progression and, in laboratory settings, successfully halted and even reversed nerve degeneration [[1]]. This discovery, led by Prof. Eran perlson and Ariel Ionescu, centers on manipulating microRNA-126 levels and TDP-43 protein aggregation [[2]], offering a new target for potential therapies.
top of page
Researchers at Tel Aviv University have identified a key molecular mechanism driving the progression of amyotrophic lateral sclerosis (ALS) and, in a significant breakthrough, demonstrated the ability to halt and even reverse nerve degeneration. This discovery offers a promising new avenue for developing effective treatments for this devastating and currently incurable neurodegenerative disease.
The international research team, led by scientists at Tel Aviv University, pinpointed a previously unknown molecular process that fuels the advancement of ALS. Their work suggests that targeting this mechanism could potentially slow or even reverse the damage caused by the disease, offering hope to patients and families affected by ALS. ALS progressively destroys motor neurons, leading to paralysis and ultimately, death, and currently has limited treatment options.
The study’s findings, recently released by the university, detail how manipulating this newly identified molecular pathway can not only stop the progression of nerve degeneration but also restore lost function. While further research is needed, these results represent a major step forward in understanding and combating ALS.
bottom of page
